Unknown

Dataset Information

0

Bowel ulceration following tocilizumab administration in a COVID-19 patient.


ABSTRACT: Tocilizumab, a monoclonal antibody against interleukin-6, has been used to treat cytokine release syndrome (CRS) in a subset of patients with severe COVID-19 disease. Acute ulcerative bowel disease has been only rarely documented in patients treated for rheumatological conditions. The gastrointestinal side effects seen when used in the context of COVID-19 are unknown. We present a case of COVID-19 CRS in which acute terminal ileum and perforated caecal ulceration evolved after tocilizumab exposure. We raise awareness of a possible causal relationship between even a single dose of tocilizumab and gut ulceration in patients with COVID-19. Any such drug enteropathy relationship requires watchful monitoring during upcoming trials of tocilizumab in patients with COVID-19.

SUBMITTER: Bruce-Hickman D 

PROVIDER: S-EPMC7437943 | biostudies-literature | 2020 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Bowel ulceration following tocilizumab administration in a COVID-19 patient.

Bruce-Hickman Damian D   Sajeed Shanaz Matthew SM   Pang Yin Huei YH   Seow Choon Sheong CS   Chen Weihao W   Gulati Kansal Monika M  

BMJ open gastroenterology 20200801 1


Tocilizumab, a monoclonal antibody against interleukin-6, has been used to treat cytokine release syndrome (CRS) in a subset of patients with severe COVID-19 disease. Acute ulcerative bowel disease has been only rarely documented in patients treated for rheumatological conditions. The gastrointestinal side effects seen when used in the context of COVID-19 are unknown. We present a case of COVID-19 CRS in which acute terminal ileum and perforated caecal ulceration evolved after tocilizumab exposu  ...[more]

Similar Datasets

| S-EPMC7645706 | biostudies-literature
| S-EPMC9428329 | biostudies-literature
| S-EPMC9374226 | biostudies-literature
| S-EPMC8084410 | biostudies-literature
| S-EPMC11367351 | biostudies-literature
| S-EPMC7840242 | biostudies-literature
| S-EPMC9650518 | biostudies-literature
| S-EPMC7431163 | biostudies-literature
| S-EPMC7531754 | biostudies-literature